idecabtagene vicleucel
2seventy bio,bms
['ide-cel']
our dr. christopher ferreri presents data evaluating real-world outcomes for patients treated with standard of care ide-cel after having previously received a bcma targeted therapy: #ash22 #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789